Brimonidine Tartrate/Timolol
Brand name: Brimonidine Tartrate-Timolol
Rank #133 of 500 drugs by total cost
$122.0M
Total Cost
361,001
Total Claims
$122.0M
Total Cost
9,739
Prescribers
$338
Cost per Claim
63,535
Beneficiaries
576,849
30-Day Fills
$13K
Avg Cost/Provider
37
Avg Claims/Provider
About Brimonidine Tartrate/Timolol
Brimonidine Tartrate/Timolol (sold as Brimonidine Tartrate-Timolol) was prescribed 361,001 times by 9,739 Medicare Part D providers in 2023, costing the program $122.0M. At $338 per claim, this is a moderately priced medication.
Related Drugs by Cost
| # | Drug | Total Cost | Claims |
|---|---|---|---|
| 130 | Immun Globg(Igg)/Malt/Iga Ov50 (Octagam) | $129.5M | 9,657 |
| 131 | Pregabalin (Pregabalin) | $124.3M | 2,696,923 |
| 132 | Dronedarone Hcl (Multaq) | $123.4M | 98,156 |
| 133 | Brimonidine Tartrate/Timolol (Brimonidine Tartrate-Timolol) | $122.0M | 361,001 |
| 134 | Olaparib (Lynparza) | $121.1M | 8,744 |
| 135 | Empagliflozin/Metformin Hcl (Synjardy Xr) | $119.7M | 121,366 |
| 136 | Edaravone (Radicava Ors) | $119.6M | 8,588 |
Data from CMS Medicare Part D Prescriber-Drug Public Use File, 2023. Methodology